Literature DB >> 11880446

Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.

Muhamed-Kheir Taha1, Isabelle Parent Du Chatelet, Martin Schlumberger, Idrissa Sanou, Saacou Djibo, François de Chabalier, Jean-Michel Alonso.   

Abstract

Meningococcal infections occur as epidemics in the African meningitis belt. Neisseria meningitidis serogroup A is predominantly involved in these epidemics. We report here new data on the involvement of both serogroups A and W135 in meningitis cases in Burkina Faso and Niger at the end of the 2001 epidemic.

Entities:  

Mesh：

Year:  2002        PMID： 11880446      PMCID： PMC120283          DOI： 10.1128/JCM.40.3.1083-1084.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Serogroup W135 meningococcal disease in Hajj pilgrims.

Authors:  M K Taha; M Achtman; J M Alonso; B Greenwood; M Ramsay; A Fox; S Gray; E Kaczmarski
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  Epidemics of meningococcal disease. African meningitis belt, 2001.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-09-14

3.  Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.

Authors:  M K Taha
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli.

Authors:  P García; J L García; E García; R López
Journal:  Gene       Date:  1986       Impact factor: 3.688

5.  Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94.

Authors:  M Guibourdenche; E A Høiby; J Y Riou; F Varaine; C Joguet; D A Caugant
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

6.  PCR for capsular typing of Haemophilus influenzae.

Authors:  T J Falla; D W Crook; L N Brophy; D Maskell; J S Kroll; E R Moxon
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

7.  Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa.

Authors:  A Kwara; R A Adegbola; P T Corrah; M Weber; M Achtman; G Morelli; D A Caugant; B M Greenwood
Journal:  Trop Med Int Health       Date:  1998-09       Impact factor: 2.622

8.  Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.

Authors:  T Popovic; C T Sacchi; M W Reeves; A M Whitney; L W Mayer; C A Noble; G W Ajello; F Mostashari; N Bendana; J Lingappa; R Hajjeh; N E Rosenstein
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883
  8 in total
  35 in total

1.  Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.

Authors:  Yih-Ling Tzeng; Corie Noble; David S Stephens
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains.

Authors:  P Nicolas; S Djibo; A Moussa; B Tenebray; P Boisier; S Chanteau
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

3.  Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors:  Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

Review 4.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.

Authors:  Pierre Nicolas; Gunnstein Norheim; Eric Garnotel; Saacou Djibo; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.

Authors:  Zhigang Jin; Gregory A Bohach; Joseph Shiloach; Scott E Norris; Darón I Freedberg; Claudia Deobald; Bruce Coxon; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 7.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

8.  Pathogenesis, Therapy, and Prevention of Meningococcal Sepsis.

Authors:  David S. Stephens; Shanta M. Zimmer
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

9.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Meningococcal disease in South Africa, 1999-2002.

Authors:  Garry B Coulson; Anne von Gottberg; Mignon du Plessis; Anthony M Smith; Linda de Gouveia; Keith P Klugman
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.